TY - JOUR
T1 - Millon Behavioral Medicine Diagnostic (MBMD) predicts health-related quality of life (HrQoL) over time among men treated for localized prostate cancer
AU - Cruess, Dean G.
AU - Benedict, Catherine
AU - Lattie, Emily G.
AU - Molton, Ivan
AU - Kinsinger, Dave
AU - Kava, Bruce
AU - Manoharan, Murugesan
AU - Soloway, Mark
AU - Penedo, Frank J.
N1 - Funding Information:
The project from which these data were drawn was supported by National Institutes of Health Grant 5 P50 CA84944. No author reported any financial interests or potential conflicts of interest. We thank Dr. Michael Antoni for his consultation in the development of this manuscript.
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Prostate cancer treatment presents multiple challenges that can negatively affect health-related quality of life (HrQoL), and that can be further compromised by maladaptive personality styles and psychological adjustment difficulties. This study examined the utility of a comprehensive psychosocial screening tool to identify psychosocial traits that prospectively predict HrQoL status among men treated for localized prostate cancer. The Millon Behavioral Medicine Diagnostic (MBMD) was administered to 66 men (M age = 68 years, 59% White) treated by either radical prostatectomy or radiotherapy along with standard measures of general and prostate-cancer-specific quality of life assessed at a 12-month follow-up. Higher scores on both summary MBMD Management Guides (Adjustment Difficulties and Psych Referral) and higher scores on personality styles characterized by avoidance, dependency, depression, passive aggressiveness, and self-denigration predicted lower HrQoL (β range =-.21 to-.50). Additionally, higher scores on the MBMD Depression, Tension-Anxiety, and Future Pessimism scales predicted lower HrQoL. Finally, higher scores on the MBMD Intervention Fragility and Utilization Excess scale also consistently predicted poorer mental and physical health functioning over time. These results point to the utility of the MBMD to help screen for potential impairments in mental and physical health functioning in men undergoing treatment for prostate cancer.
AB - Prostate cancer treatment presents multiple challenges that can negatively affect health-related quality of life (HrQoL), and that can be further compromised by maladaptive personality styles and psychological adjustment difficulties. This study examined the utility of a comprehensive psychosocial screening tool to identify psychosocial traits that prospectively predict HrQoL status among men treated for localized prostate cancer. The Millon Behavioral Medicine Diagnostic (MBMD) was administered to 66 men (M age = 68 years, 59% White) treated by either radical prostatectomy or radiotherapy along with standard measures of general and prostate-cancer-specific quality of life assessed at a 12-month follow-up. Higher scores on both summary MBMD Management Guides (Adjustment Difficulties and Psych Referral) and higher scores on personality styles characterized by avoidance, dependency, depression, passive aggressiveness, and self-denigration predicted lower HrQoL (β range =-.21 to-.50). Additionally, higher scores on the MBMD Depression, Tension-Anxiety, and Future Pessimism scales predicted lower HrQoL. Finally, higher scores on the MBMD Intervention Fragility and Utilization Excess scale also consistently predicted poorer mental and physical health functioning over time. These results point to the utility of the MBMD to help screen for potential impairments in mental and physical health functioning in men undergoing treatment for prostate cancer.
UR - http://www.scopus.com/inward/record.url?scp=84872017081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872017081&partnerID=8YFLogxK
U2 - 10.1080/00223891.2012.681819
DO - 10.1080/00223891.2012.681819
M3 - Article
C2 - 22571442
AN - SCOPUS:84872017081
SN - 0022-3891
VL - 95
SP - 54
EP - 61
JO - Journal of Personality Assessment
JF - Journal of Personality Assessment
IS - 1
ER -
